Evaluation of the Impact of Surfactant Digestion on the Bioavailability of Danazol after Oral Administration of Lipidic Self-Emulsifying Formulations to Dogs

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (39)

• Absorption of Danazol After Administration to Different Sites of the Gastrointestinal Tract and the Relationship to Single‐ and Double‐Peak Phenomena in the Plasma Profiles via openalex
• A dynamic in vitro lipolysis model via openalex
• Increasing the Proportional Content of Surfactant (Cremophor EL) Relative to Lipid in Self-emulsifying Lipid-based Formulations of Danazol Reduces Oral Bioavailability in Beagle Dogs via openalex
• Relative bioavailability of danazol in dogs from liquid-filled hard gelatin capsules via openalex
• Solubilization and Wetting Effects of Bile Salts on the Dissolution of Steroids via openalex
• Susceptibility to Lipase-Mediated Digestion Reduces the Oral Bioavailability of Danazol After Administration as a Medium-Chain Lipid-Based Microemulsion Formulation via openalex
• doi:10.1016/j.ijpharm.2003.12.028 via openalex
• doi:10.1016/j.ejps.2004.08.003 via openalex
• doi:10.1081/ddc-100000125 via openalex
• doi:10.1016/s0378-5173(97)00325-6 via openalex
• doi:10.1007/s11095-006-9054-x via openalex
• doi:10.1021/j100210a011 via openalex
• doi:10.1016/j.jcis.2006.12.015 via openalex
• doi:10.1080/03639040500215750 via openalex
• W2417194615 via openalex
• W2433102311 via openalex
• doi:10.1016/s0378-5173(98)00054-4 via openalex
• doi:10.1023/a:1015987223407 via openalex
• doi:10.1002/jps.10329 via openalex
• doi:10.1038/nrd2197 via openalex
• doi:10.1021/bi00460a011 via openalex
• doi:10.1016/s0169-409x(96)00489-9 via openalex
• doi:10.1016/s0731-7085(00)00528-8 via openalex
• doi:10.1016/s0022-2275(20)36977-7 via openalex
• doi:10.1016/s0022-2275(20)39696-6 via openalex
• doi:10.1211/0022357021771896 via openalex
• doi:10.1016/j.biopha.2004.02.001 via openalex
• doi:10.1016/s0928-0987(00)00167-6 via openalex
• doi:10.1016/s0378-5173(97)00248-2 via openalex
• doi:10.1016/j.jconrel.2005.10.002 via openalex
• doi:10.1002/1522-2683(200204)23:7/8<1053::aid-elps1053>3.0.co;2-3 via openalex
• doi:10.1016/j.bbalip.2007.02.009 via openalex
• doi:10.1023/a:1015843517762 via openalex
• doi:10.1016/j.ijpharm.2004.08.024 via openalex
• doi:10.1002/jps.20039 via openalex
• doi:10.1002/jps.10554 via openalex
• doi:10.1016/j.ejps.2006.04.016 via openalex
• doi:10.1021/j150668a023 via openalex
• doi:10.1016/0378-5173(85)90081-x via openalex

Cited by (6)

• Danazol 2022
• <i>In Vivo</i> Precipitation of Poorly Soluble Drugs from Lipid-Based Drug Delivery Systems 2016
• Application of Capmul MCM and caprylic acid for the development of danazol-loaded SEDDS 2014
• An in Vitro Digestion Test That Reflects Rat Intestinal Conditions To Probe the Importance of Formulation Digestion vs First Pass Metabolism in Danazol Bioavailability from Lipid Based Formulations 2014
• Evaluation of a Nanoemulsion Formulation Strategy for Oral Bioavailability Enhancement of Danazol in Rats and Dogs 2013
• Lipid-based Formulations for Danazol Containing a Digestible Surfactant, Labrafil M2125CS: In Vivo Bioavailability and Dynamic In Vitro Lipolysis 2008

Source provenance

openalex

last seen: 2026-05-14T06:08:44.784461+00:00